Items 1 through 9 and Item 11.
The Offer to Purchase and Items 1 through 9 and Item 11 of the Schedule TO, to the extent such Items incorporate by reference the information contained in the Offer to Purchase, are hereby amended and supplemented by adding the following paragraphs thereto:
“On December 14, 2022, Purchaser announced an extension of the Expiration Time until 11:59 p.m., New York City time, on December 21, 2022, unless the Offer is further extended or earlier terminated as permitted by the Merger Agreement. The Offer was previously scheduled to expire at 11:59 p.m., New York City time, on December 13, 2022.
The Depositary has advised Purchaser that, as of 6 p.m., New York City time, on December 13, 2022, approximately 19,279,461 Shares have been validly tendered and not properly withdrawn pursuant to the Offer, representing approximately 42.75% of the outstanding Shares.
The press release announcing the extension of the Offer is attached hereto as Exhibit (a)(5)(G) and incorporated herein by reference.”
Amendments to the Offer to Purchase and Exhibits to the Schedule TO
All references to “11:59 p.m., New York City time, on December 13, 2022” set forth in the Offer to Purchase (Exhibit (a)(1)(A)), Form of Letter of Transmittal (Exhibit (a)(1)(B)), Form of Notice of Guaranteed Delivery (Exhibit (a)(1)(C)), Form of Letter to Brokers, Dealers, Banks, Trust Companies and Other Nominees (Exhibit (a)(1)(D)), and Form of Letter to Clients for use by Brokers, Dealers, Banks, Trust Companies and Other Nominees (Exhibit (a)(1)(E)) are hereby amended and replaced with “11:59 p.m., New York City time, on December 21, 2022.”
Item 12. Exhibits.
Item 12 of the Schedule TO is hereby amended and supplemented by adding the following exhibit:
| | |
Exhibit No. | | Description |
| |
(a)(5)(G) | | Press Release issued by Johnson & Johnson, dated December 14, 2022 |